Using RNA to Amplify RNA

Researchers apply in vitro evolution to generate an RNA enzyme capable of copying and amplifying RNA.

By | August 15, 2016

WIKIMEDIA, LUCASHARRRNA self-replication is a key part of the RNA world hypothesis, but generating ribozymes in the lab that can synthesize, replicate, and amplify functional RNA molecules with complex structures has proven difficult. Until now, the most successful variants of the class I RNA polymerase ribozyme have worked inefficiently even on their preferred template: short, simple RNA sequences with a high concentration of pyrimidines.

In a paper published today (August 15) in PNAS, scientists from the Scripps Research Institute in La Jolla, California, report on their use of in vitro evolution to generate an improved polymerase ribozyme that can synthesize multiple functional, structured RNAs and amplify short RNA templates.

The research “has extended the capabilities of RNA to RNA polymerization in ways that have not been achieved before,” said Scott Silverman of the University of Illinois at Urbana-Champaign, who did not participate in the work. “It’s definitely a key advance in the field of understanding what RNA polymerase ribozymes can do, and it has pretty important implications for the RNA world theory,” he added.

Study coauthors Gerald Joyce and David Horning of Scripps began with a variant of the class I RNA polymerase ribozyme. They introduced random mutations throughout its sequence to generate 100 trillion variants. Joyce and Horning then applied pressure to this population, by priming the ribozymes to complete RNA aptamers—molecules that bind to a synthetic form of vitamin B12 or to GTP. Each round, the researchers selected for ribozymes that produced functional products, products of the correct length, or both.

The researchers increased the stringency of selection for successive generations by requiring the ribozymes to synthesize longer RNA molecules in less time. By the 24th round, the population could synthesize purine-rich, functional RNA sequences.

From this population, Horning and Joyce isolated a variant of the ribozyme called 24-3, which had 17 mutations. The 24-3 polymerase used all four bases and functioned much more quickly than the starting polymerase. It was capable of copying multiple functional RNAs with complex secondary structures, including aptamers, other ribozymes, and yeast transfer RNA (tRNA). The researchers showed that 24-3 could also amplify short RNA templates exponentially in an RNA-only version of PCR.

“It’s really beautiful work and a major step towards the realization of RNA self-replication,” Philipp Holliger of the MRC Laboratory of Molecular Biology in Cambridge, U.K., who did not participate in the work, wrote in an email to The Scientist.

“What Horning and Joyce have done here is a wonderful step forward,” said Donald Burke-Agüero of the University of Missouri, who also did not participate in the research. “It puts us much closer to having an RNA replication system that can sustain replication of RNA, but it’s not there yet.”

The 24-3 polymerase ribozyme cannot copy itself, however. Although yeast tRNA is highly structured and large compared to products synthesized by earlier polymerase ribozymes, the 24-3 ribozyme is three times larger than yeast tRNA and contains even more complex structural elements.

Joyce, Horning, and colleagues are working to overcome this limitation with ongoing in vitro evolution experiments. Stricter selection criteria should prompt the ribozyme to make larger, more complicated functional products more efficiently, the researchers said, though it’s not clear how many test tube generations it will take to achieve this.

Meantime, Joyce pointed to the evolutionary biology research application of studying the evolution of a self-replicating ribozyme. “If you had an RNA enzyme that was an RNA replicase that could copy RNAs exponentially, including copies of itself, then I would say it’s alive,” said Joyce . “Then it’s up to evolution. Whatever makes it better makes it better.”

D.P. Horning and G.F. Joyce, “Amplification of RNA by an RNA polymerase ribozyme,” PNAS, doi:10.1073/pnas.1610103113, 2016.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: James V. Kohl

James V. Kohl

Posts: 481

August 16, 2016

See for comparison: Codon identity regulates mRNA stability and translation efficiency during the maternal-to-zygotic transition

The authors established the fact that ecological variation links energy-dependent selection for codon usage to biophysically constrained RNA-mediated protein folding biochemistry in the context of nutrient energy-dependent RNA-mediated amino acid substitutions.

The substitutions link metabolic networks and genetic networks via the innate immune system in the context of the physiology of reproduction, and the substitutions also link the sun's anti-entropic virucidal energy as quantised information to supercoiled DNA, which prevents virus-driven genomic entropy in all living genera.

Excerpt:

"The amino acid optimality code (Fig 6) provides an alternative perspective on sequence changes between paralogs in evolution and human disease."

Horning, Joyce, and other theorists consistently fail to suggest how virus-driven energy theft and genomic entropy can be removed from their model without defeating the purpose of a model. 

Models that cannot be validated by anyone who has already linked energy-dependent changes from angstroms to ecosystems in all living genera have no explanatory power. They are the "Just-So" stories of theorists. 

See for comparison: Structural diversity of supercoiled DNA

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip